| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
114 |
98 |
$4K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
77 |
66 |
$1K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
58 |
58 |
$917.37 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
50 |
50 |
$875.18 |
| 93000 |
|
46 |
40 |
$674.76 |
| G0271 |
Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes |
48 |
44 |
$651.00 |
| 99386 |
|
12 |
12 |
$351.33 |
| 97802 |
|
77 |
68 |
$256.97 |
| 3074F |
|
93 |
84 |
$125.00 |
| 3078F |
|
87 |
75 |
$117.50 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
57 |
55 |
$16.10 |
| 1159F |
|
56 |
56 |
$10.00 |
| 1160F |
|
56 |
56 |
$10.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
53 |
53 |
$9.00 |
| 1126F |
|
121 |
105 |
$5.00 |
| 94760 |
|
154 |
130 |
$4.63 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
105 |
91 |
$4.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
123 |
108 |
$4.00 |
| H0001 |
Alcohol and/or drug assessment |
52 |
52 |
$0.08 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
46 |
46 |
$0.07 |
| 3016F |
|
57 |
57 |
$0.00 |
| G9383 |
Patient received screening for hcv infection within the 12 month reporting period |
53 |
51 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
53 |
53 |
$0.00 |
| 1033F |
|
42 |
42 |
$0.00 |
| G0435 |
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening |
32 |
30 |
$0.00 |
| 3725F |
|
57 |
57 |
$0.00 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
31 |
29 |
$0.00 |
| 4293F |
|
62 |
58 |
$0.00 |
| 1000F |
|
53 |
53 |
$0.00 |
| 3008F |
|
121 |
105 |
$0.00 |
| 99429 |
|
98 |
86 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
55 |
50 |
$0.00 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
31 |
29 |
$0.00 |
| 1036F |
|
44 |
44 |
$0.00 |
| 3017F |
|
12 |
12 |
$0.00 |